Allogene Therapeutics (ALLO)
(Delayed Data from NSDQ)
$2.61 USD
+0.02 (0.77%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $2.60 -0.01 (-0.38%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.29 | 10.20% |
Earnings Summary
For their last quarter, Allogene Therapeutics (ALLO) reported earnings of -$0.32 per share, beating the Zacks Consensus Estimate of $-0.35 per share. This reflects a positive earnings surprise of 8.57%. Look out for ALLO's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.29 per share, reflecting a year-over-year increase of 21.62%.
Earnings History
Price & Consensus
Zacks News for ALLO
Poseida Therapeutics, Inc. (PSTX) Reports Q2 Loss, Tops Revenue Estimates
ALLO: What are Zacks experts saying now?
Zacks Private Portfolio Services